rs10502661
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001281740.3(FHOD3):c.511+27649C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0658 in 152,228 control chromosomes in the GnomAD database, including 526 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.066 ( 526 hom., cov: 32)
Consequence
FHOD3
NM_001281740.3 intron
NM_001281740.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.363
Publications
4 publications found
Genes affected
FHOD3 (HGNC:26178): (formin homology 2 domain containing 3) The protein encoded by this gene is a member of the diaphanous-related formins (DRF), and contains multiple domains, including GBD (GTPase-binding domain), DID (diaphanous inhibitory domain), FH1 (formin homology 1), FH2 (formin homology 2), and DAD (diaphanous auto-regulatory domain) domains. This protein is thought to play a role in actin filament polymerization in cardiomyocytes. Mutations in this gene have been associated with dilated cardiomyopathy (DCM), characterized by dilation of the ventricular chamber, leading to impairment of systolic pump function and subsequent heart failure. Increased levels of the protein encoded by this gene have been observed in individuals with hypertrophic cardiomyopathy (HCM). Alternative splicing results in multiple transcript variants encoding different isoforms. A muscle-specific isoform has been shown to possess a casein kinase 2 (CK2) phosphorylation site at the C-terminal end of the FH2 domain. Phosphorylation of this site alters its interaction with sequestosome 1 (SQSTM1), and targets this isoform to myofibrils, while other isoforms form cytoplasmic aggregates. [provided by RefSeq, Aug 2015]
FHOD3 Gene-Disease associations (from GenCC):
- cardiomyopathy, familial hypertrophic, 28Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- hypertrophic cardiomyopathyInheritance: AD Classification: MODERATE Submitted by: Illumina
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.211 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FHOD3 | ENST00000590592.6 | c.511+27649C>T | intron_variant | Intron 5 of 28 | 1 | NM_001281740.3 | ENSP00000466937.1 | |||
| FHOD3 | ENST00000257209.8 | c.511+27649C>T | intron_variant | Intron 5 of 24 | 1 | ENSP00000257209.3 | ||||
| FHOD3 | ENST00000359247.8 | c.511+27649C>T | intron_variant | Intron 5 of 23 | 1 | ENSP00000352186.3 | ||||
| FHOD3 | ENST00000589114.5 | n.630+27649C>T | intron_variant | Intron 5 of 13 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0658 AC: 10006AN: 152110Hom.: 526 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
10006
AN:
152110
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0658 AC: 10010AN: 152228Hom.: 526 Cov.: 32 AF XY: 0.0686 AC XY: 5106AN XY: 74434 show subpopulations
GnomAD4 genome
AF:
AC:
10010
AN:
152228
Hom.:
Cov.:
32
AF XY:
AC XY:
5106
AN XY:
74434
show subpopulations
African (AFR)
AF:
AC:
1202
AN:
41534
American (AMR)
AF:
AC:
2127
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
67
AN:
3472
East Asian (EAS)
AF:
AC:
265
AN:
5182
South Asian (SAS)
AF:
AC:
1068
AN:
4820
European-Finnish (FIN)
AF:
AC:
451
AN:
10604
Middle Eastern (MID)
AF:
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4635
AN:
68006
Other (OTH)
AF:
AC:
118
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
462
924
1385
1847
2309
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
416
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.